Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on: July 10,2024

Regorafenib synergizes with TAS102 against multiple gastrointestinal cancers: Study

by Impact Journals LLCTAS102 in combination with regorafenib inhibits ERK1/2 and STAT3 signaling. Credit: 2024 Zhang et al.A new research paper waspublishedinOncotargettitled,

Updated on:July 10,2024

Researchers investigate cancer cluster in Alabama town

by Lindsey Piercy,University of KentuckyCredit: Unsplash/CC0 Public DomainFruithurst is your quintessential small town. Located in Cleburne County, Alabama—just five miles on the other side of t

Updated on: February 20,2024

Researchers investigate cancer cluster in Alabama town

by Lindsey Piercy,University of KentuckyCredit: Unsplash/CC0 Public DomainFruithurst is your quintessential small town. Located in Cleburne County, Alabama—just five miles on the other side of t

Updated on:February 20,2024

Epidemiological studies on gastroesophageal reflux disease and esophageal cancer

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainEsophageal cancer is the seventh most common cancer world-wide and a lethal malignancy causing a considerably high number of deaths. There

Updated on: January 10,2024

Epidemiological studies on gastroesophageal reflux disease and esophageal cancer

byKarolinska InstitutetCredit: Pixabay/CC0 Public DomainEsophageal cancer is the seventh most common cancer world-wide and a lethal malignancy causing a considerably high number of deaths. There

Updated on:January 10,2024

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

by UF HealthGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112235A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell m

Updated on: January 22,2024

Two mutations team up to cloak a deadly brain cancer from the immune system, study suggests

by UF HealthGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2023.112235A new study of the aggressive brain cancer glioblastoma suggests that two specific cancer cell m

Updated on:January 22,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on: December 02,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on:December 02,2024

New radiation technology raises a stir

by Netherlands Organisation for Scientific Research (NWO)Credit: Netherlands Organisation for Scientific Research (NWO)Nothing less than a breakthrough. That's how researchers at UMC Utrecht

Updated on: March 12,2024

New radiation technology raises a stir

by Netherlands Organisation for Scientific Research (NWO)Credit: Netherlands Organisation for Scientific Research (NWO)Nothing less than a breakthrough. That's how researchers at UMC Utrecht

Updated on:March 12,2024

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s

Updated on: December 28,2023

Chlorhexidine disinfectant may perform best in killing bone tumor cells after surgery

byWolters Kluwer HealthThe widely used disinfectant chlorhexidine gluconate (CHG) appears to be the most effective irrigation solution for use as part of the surgical treatment of bone tumors, s

Updated on:December 28,2023

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on: February 20,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on:February 20,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on: January 03,2024

Three doses of COVID-19 mRNA vaccine associated with better outcomes for patients with cancer

byDana-Farber Cancer InstituteForest plot showing results of the multivariable logistic regression analysis following IPTW for the primary endpoint of 30-day mortality among patients with cancer

Updated on:January 03,2024

More evidence HPV vaccine reduces precancerous lesions

byUniversity of OtagoGardasil vaccine and box. Image: WikipediaThe HPV vaccine has led to a significant reduction in the rate of cervical abnormalities in young New Zealand women, which is likel

Updated on: December 20,2023

More evidence HPV vaccine reduces precancerous lesions

byUniversity of OtagoGardasil vaccine and box. Image: WikipediaThe HPV vaccine has led to a significant reduction in the rate of cervical abnormalities in young New Zealand women, which is likel

Updated on:December 20,2023

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Updated on: March 25,2024

A new approach for bolstering the ability of T cells to fight cancer

by Monash UniversityCredit: CC0 Public DomainA collaborative study led by the Monash Biomedicine Discovery Institute (BDI) has discovered a new immune checkpoint that may be exploited for cancer

Updated on:March 25,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on: November 15,2024

Neoantigen DNA Vaccines: A Promising Approach for Triple Negative Breast Cancer

Among innovative strategies, neoantigen DNA vaccines have emerged as a particularly promising approach, offering hope for improved patient outcomes.

Updated on:November 15,2024